Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - docetaxel 10 mg/ml - solution for infusion - 10 mg/ml - active: docetaxel 10 mg/ml excipient: citric acid ethanol macrogol 300 nitrogen as needed polysorbate 80 - treatment of patients with locally advanced or metastatic breast cancer in whom previous chemotherapy has failed. dbl docetaxel, concentrated injection in combination with capecitabine is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior anthracycline containing chemotherapy. dbl™ docetaxel, concentrated injection in combination with trastuzumab is indicated for the treatment of patients with metastatic breast cancer whose tumours overexpress her2 and who previously have not received chemotherapy for metastatic disease.

Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

actavis new zealand limited - docetaxel 140mg - concentrate for injection - 140 mg - active: docetaxel 140mg excipient: citric acid ethanol nitrogen polysorbate 80 povidone

Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - docetaxel 20mg - concentrate for injection - 20 mg - active: docetaxel 20mg excipient: citric acid ethanol nitrogen polysorbate 80 povidone

Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - docetaxel 80mg - concentrate for injection - 80 mg - active: docetaxel 80mg excipient: citric acid ethanol nitrogen polysorbate 80 povidone

Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - anastrozole 1mg - film coated tablet - 1 mg - active: anastrozole 1mg excipient: hypromellose lactose monohydrate magnesium stearate opadry white y-1-7000 povidone sodium starch glycolate - treatment of advanced breast cancer in post-menopausal women.

Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

viatris limited - galantamine hydrobromide 20.512mg equivalent to galantamine 16 mg;   - modified release capsule - 16 mg - active: galantamine hydrobromide 20.512mg equivalent to galantamine 16 mg   excipient: allura red ac gelatin hydrogenated vegetable oil kollidon sr magnesium stearate povidone tekprint black sw-9008 titanium dioxide   - galantyl is indicated for the treatment of mild to moderately severe dementia of the alzheimer type.

Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

viatris limited - galantamine hydrobromide 30.768mg equivalent to galantamine 24 mg;   - modified release capsule - 24 mg - active: galantamine hydrobromide 30.768mg equivalent to galantamine 24 mg   excipient: allura red ac gelatin hydrogenated vegetable oil kollidon sr magnesium stearate povidone tekprint black sw-9008 titanium dioxide   - galantyl is indicated for the treatment of mild to moderately severe dementia of the alzheimer type.

Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

viatris limited - galantamine hydrobromide 10.256mg equivalent to galantamine 8 mg;   - modified release capsule - 8 mg - active: galantamine hydrobromide 10.256mg equivalent to galantamine 8 mg   excipient: allura red ac gelatin hydrogenated vegetable oil kollidon sr magnesium stearate povidone tekprint black sw-9008 titanium dioxide   - galantyl is indicated for the treatment of mild to moderately severe dementia of the alzheimer type.

Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

rex medical ltd - gemcitabine hydrochloride 1138mg equivalent to gemcitabine 1 g - powder for infusion - 1000 mg - active: gemcitabine hydrochloride 1138mg equivalent to gemcitabine 1 g excipient: hydrochloric acid mannitol sodium acetate trihydrate sodium hydroxide - gemcitabine, alone or in combination with cisplatin, is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer.

Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

rex medical ltd - gemcitabine hydrochloride 227.6mg equivalent to gemcitabine 200 mg - powder for infusion - 200 mg - active: gemcitabine hydrochloride 227.6mg equivalent to gemcitabine 200 mg excipient: hydrochloric acid mannitol sodium acetate trihydrate sodium hydroxide - gemcitabine, alone or in combination with cisplatin, is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer.